Breast cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at adding patritumab deruxtecan to certain cancer drugs for breast cancer.
It is for people whose breast cancer:
has spread into surrounding tissues and can’t be treated with surgery or it has spread to another part of the body
is breast cancer
You pronounce patritumab deruxtecan as pat-ree-too-mab deh-rux-tee-can.
Recruitment start: 22 July 2025
Recruitment end: 10 August 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Elisavet Papadimitraki
Merck Sharp & Dohme Ltd
Last reviewed: 08 Oct 2025
CRUK internal database number: 20106
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
